SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 185.86-0.1%Feb 11 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (7442)9/24/1997 7:00:00 PM
From: Andrew H   of 32384
 
I always think about what you say TD. However, since LGND owns targretin entirely, AGN may have had them over a barrel, but it wasn't the targretin barrel. Probably something of a diabetes barrel. Anyway, Henry will explain in for us--the intricacies here are too complex .

You make a good point that that AGN must like the P2 targretin results. However, if LGND gives their partner 50% of targretin, that only leaves them 1/3 of the total. Oh, well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News